| AD | Activation domains |
| AP2/ERF | APETALA 2/ethylene-responsive element binding factor |
| ARF | Auxin response transcription factor |
| ATM | Ataxia-Telangiectasia-Mutated |
| bHLH | Basic helix-loop-helix |
| bZIP | Basic leucine zipper |
| DREB2A | Dehydration-Responsive Element Binding Protein 2A |
| DBD | DNA-binding domain |
| DDR | DNA damage response |
| EAR | ERF-associated amphiphilic repression |
| IAA | Auxin |
| IDR | Intrinsically disordered regions |
| ID | Intrinsic disorder |
| JA | Jasmonic acid |
| JID | JAZ-interacting domain |
| MED | Mediator |
| MoRF | Molecular recognition features |
| MYB | Myeloblastosis |
| MYC | Myelocytomatosis |
| NAC | NAM/ATAF1/CUC2 |
| PB1 | Phox and Bem1p |
| PrLD | Prion-like domain |
| PCF | Proliferating Cell Nuclear Factor |
| PTM | Posttranslational modification |
| RCD1 | Radical Induced Cell Death1 |
| RBS | RCD1-binding SLiM |
| SA | Salicylic acid |
| SQ | Serine-glutamine |
| SLiM | Short linear motif |
| SUMO | Small ubiquitin-like modifier |
| SOG1 | Suppressor of Gamma Response 1 |
| TA | Transcriptional activation |
| TCP | Teosinte branched1, cycloidea, proliferating cell nuclear factor |
| TF | Transcription factors |
| TR | Transcriptional repression |
| TRD | Transcription regulatory domain |
| UPS | Ubiquitin proteasome system |
| VRN1 | Vernalization 1 |